Roberto Giugliani
Universidade Federal do Rio Grande do Sul · 1,458 works · 25,862 citations · h-index 82
Top works
- Epidemiology of mucopolysaccharidoses
- A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
- Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
- Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data
- Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)
- Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism
- Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder
- Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
- Direct Comparison of Measures of Endurance, Mobility, and Joint Function During Enzyme-Replacement Therapy of Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome): Results After 48 Weeks in a Phase 2 Open-Label Clinical Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase
- Management Guidelines for Mucopolysaccharidosis VI
- Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survey
- Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
- The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families
- Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
- Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
- The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported
- Multidisciplinary Management of Hunter Syndrome
- Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
- Initial report from the Hunter Outcome Survey
- A Prospective, Cross-sectional Survey Study of the Natural History of Niemann-Pick Disease Type B